The ones used in rheumatalogical diseases:
http://www.nytimes.com/2008/06/05/business/05drug.html?_r=1&adxnnl=1&oref=slogin&adxnnlx=1212754177-LbbG62wE+sPOGC65MDggOQ
Misleading title .. change it to Rheumatoid Arthritis drugs.
BIG DIFFERENCE !
Done, Jason.
The risk of lymphoma is raised in patients with rheumatoid anyway, and so far, no increased risk has been detected with the anti-tnf drugs. This is something that rheumatologists have long been aware of, and have been looking for any signal for a long time.
It's callled the SETI project .. Seeking Extra risk from Tnf Inhibitors.
Graham http://www.synapsedirect.com/ Synapse - the EMR for smart users
Thirty cases in ten years? That's it? As gchui says "The risk of lymphoma is raised in patients with rheumatoid anyway".
In derm, we use anti-tnf drugs more and more, but not on children. Based on my limited experience, Remicade is a miracle drug,